New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Lifeist Wellness Inc.
LFST.V
Shape
US Flag

TSXV

Unprofitable

EPS improving

Unprofitable

EPS improving

2M

Drug Manufacturers - Specialty & Generic

Next Earning date - 25 Oct 2024

2M

Drug Manufacturers - Specialty & Generic

Next Earning date - 25 Oct 2024

0.06CAD
Shape-0.01 ( -14.29%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-73%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

80%

Quote Panel

Shape
Updated October 26, 2024
1W -20.00 % 1M -33.33 % 3M -45.45 % 1Y -80.00 %

Key Metrics

Shape
  • Market Cap

    2.49M


  • Shares Outstanding

    42.41M


  • Share in Float

    35.01M


  • Dividende

    0


  • Earning Date

    25 Oct 2024


  • Price Target

    0.06


  • Average Volume

    37871


  • Beta

    1.236


  • Range

    0.05-0.3


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.lifeist.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.14x

P/S Ratio

-4.48x

P/B Ratio

-2.8

Debt/Equity

-68.4%

Net Margin

$-0.6

EPS

How LFST.V compares to sector?

P/E Ratio

Relative Strength

Shape

LFST.V

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.19
vs -0.32

Q2.22

arrow
arrow

N/A

-0.09
vs -0.31

Q3.22

arrow
arrow

N/A

NA
vs NA

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

-0.15
vs -0.19

Q2.23

arrow
arrow

N/A

-0.10
vs -0.09

Q3.23

arrow
arrow

N/A

NA
vs NA

Q4.23

arrow
arrow

N/A

NA
vs NA

Q1.24

arrow
arrow

N/A

-0.09
vs -0.15

Q2.24

arrow
arrow

+100%

NA
vs -0.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-1%

5.5M  vs 5.5M

Q2.22

arrow
arrow

-22%

4.1M  vs 5.3M

Q3.22

arrow
arrow

+18%

6.8M  vs 5.8M

Q4.22

arrow
arrow

0%

6.2M  vs 6.2M

Q1.23

arrow
arrow

+8%

5.9M  vs 5.5M

Q2.23

arrow
arrow

+51%

6.2M  vs 4.1M

Q3.23

arrow
arrow

-30%

4.8M  vs 6.8M

Q4.23

arrow
arrow

-24%

4.7M  vs 6.2M

Q1.24

arrow
arrow

-17%

4.9M  vs 5.9M

Q2.24

arrow
arrow

-37%

3.9M  vs 6.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-10%

-0.10
vs -0.18

Q4.22

arrow
arrow

-61%

-0.61
vs -0.10

Q1.23

arrow
arrow

-31%

-0.31
vs -0.61

Q2.23

arrow
arrow

-24%

-0.24
vs -0.31

Q3.23

arrow
arrow

-25%

-0.25
vs -0.24

Q4.23

arrow
arrow

-181%

-1.81
vs -0.25

Q1.24

arrow
arrow

-231%

-2.31
vs -1.81

Q2.24

arrow
arrow

+358%

3.58
vs -2.31

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News